Catalogo dei prodotti della ricerca

CIPPITELLI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.131
EU - Europa 1.437
AS - Asia 473
AF - Africa 32
SA - Sud America 30
Totale 5.103
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.111
IT - Italia 713
DE - Germania 234
SG - Singapore 200
IN - India 144
CN - Cina 87
UA - Ucraina 87
NL - Olanda 68
FI - Finlandia 65
FR - Francia 65
SE - Svezia 64
RU - Federazione Russa 40
GB - Regno Unito 38
TG - Togo 27
BG - Bulgaria 21
CA - Canada 18
KR - Corea 16
AR - Argentina 11
CH - Svizzera 8
IE - Irlanda 8
IR - Iran 8
RO - Romania 7
CL - Cile 6
BR - Brasile 5
BE - Belgio 4
ES - Italia 4
TR - Turchia 4
BO - Bolivia 3
DK - Danimarca 3
HK - Hong Kong 3
IL - Israele 3
JP - Giappone 3
NG - Nigeria 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AT - Austria 2
EC - Ecuador 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
MK - Macedonia 1
MX - Messico 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
TH - Thailandia 1
Totale 5.103
Salva come PNG Salva come JPEG
Città #
Fairfield 466
Rome 334
Ashburn 317
Woodbridge 273
Seattle 205
Houston 203
Chandler 194
Cambridge 160
Dearborn 144
Wilmington 138
Ann Arbor 124
Singapore 113
Princeton 75
Paris 60
Plano 60
Lawrence 56
Fasano 55
San Paolo di Civitate 55
Boston 40
Beijing 36
Jacksonville 32
San Diego 28
Lomé 27
Millbury 23
Sofia 21
Andover 20
New York 19
Pune 16
Tivoli 16
Falls Church 15
Norwalk 15
Helsinki 14
Phoenix 13
Washington 12
Federal 11
Fremont 11
Milan 11
Hefei 9
Kunming 9
Dublin 8
San Jose 8
Santa Clara 8
Ancona 7
Key Biscayne 7
Mannheim 7
Nanjing 7
Ottawa 7
Toronto 7
Boardman 6
Bühl 6
Los Angeles 6
Sacramento 6
Dongjak-gu 5
London 5
Padova 5
Parma 5
Santiago 5
Amsterdam 4
Artena 4
Brussels 4
Castel Gandolfo 4
Des Moines 4
Madrid 4
Seongbuk-gu 4
Atlanta 3
Bern 3
Dallas 3
Duarte 3
Grafing 3
Jinan 3
Leverano 3
Monterotondo 3
Nanchang 3
New Delhi 3
Palermo 3
Pohang 3
Rimini 3
Rødovre Municipality 3
San Valentino Torio 3
Southend 3
São Paulo 3
Albuquerque 2
Ankara 2
Ariccia 2
Beersheba 2
Blacksburg 2
Bremen 2
Brescia 2
Camerino 2
Canary Wharf 2
Capannori 2
Codroipo 2
Ercolano 2
Falkenstein 2
Fiuggi 2
Florence 2
Frankfurt am Main 2
Genazzano 2
Guayaquil 2
Hangzhou 2
Totale 3.662
Salva come PNG Salva come JPEG
Nome #
Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70/TLR2/NF-kB axis 157
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells 151
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells. role of cMYC-IRF4-miR-125b interplay 151
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma 138
Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle-associated MICA. Dual role in cancer immunosurveillance 129
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation 127
Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms 121
Drug-induced senescent Multiple Myeloma cells elicit NK cell proliferation by direct or exosome-mediated IL-15 trans-presentation 113
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in multiple myeloma. modulation by bromodomain and Extra-Terminal (BET) protein inhibitors 112
Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells 110
Immunoregulatory and effector activities of nitric oxide and reactive nitrogen species in cancer 108
Hyperthermia enhances CD95-ligand gene expression in T lymphocytes 103
Targeting NKG2D and NKp30 ligands shedding to improve NK cell–based immunotherapy 99
Bone marrow stromal cell-derived IL-8 upregulates PVR expression on multiple myeloma cells via NF-kB transcription factor 97
Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression 95
null 92
NKG2D and its ligands: one for all, all for one 90
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis 88
Translating the anti-myeloma activity of Natural Killer cells into clinical application 85
Key role of the CD56lowCD16low Natural Killer cell subset in the recognition and killing of Multiple Myeloma cells 85
IL-15 inhibits IL-7Rα expression by memory-phenotype CD8⁺ T cells in the bone marrow. 84
MICA-129 dimorphism and soluble MICA are associated with the progression of multiple myeloma 83
The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells 82
Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells 80
The POU-Domain Transcription Factor Oct-6/POU3F1 as a Regulator of Cellular Response to Genotoxic Stress 80
Activation of nuclear factor of activated T cells in a cyclosporin A-resistant pathway. 73
ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK cell susceptibility and is associated with a senescent phenotype 73
Reactive Oxygen Species- and DNA Damage Response-Dependent NK Cell Activating Ligand Upregulation Occurs at Transcriptional Levels and Requires the Transcriptional Factor E2F1. 72
CD155: a multi-functional molecule in tumor progression 71
Identification of a Stat-6-responsive element in the promoter of the human interleukin-4 gene 67
Natural killer cell response to chemotherapy-stressed cancer cells: Role in tumor immunosurveillance. 67
Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma 67
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer 66
Soluble and cell-associated IL-2 receptor (IL-2R) after local immunotherapy with recombinant interleukin-2 (rIL-2). 63
Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3 63
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma 62
Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. 62
null 62
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation 62
The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: Inhibition of AP1 binding and activation of a silencer element 61
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles 60
Role of aiolos and ikaros in the antitumor and immunomodulatory activity of imids in multiple myeloma: better to lose than to find them 60
Negative regulation of CD95-ligand gene expression by vitamin D3 in T lymphocytes. 59
relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells 59
The activation of the DNA damage response regulate the expression of DNAM-1 and NKG2D activating receptor ligands on human multiple myeloma (MM) cells. 58
Heat Shock Protein-90 Inhibitors Increase MHC Class I-Related Chain A and B Ligand Expression on Multiple Myeloma Cells and Their Ability to Trigger NK Cell Degranulation 58
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene 57
Vitamin D3: a transcriptional modulator of the interferon-gamma gene. 54
Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells 51
15-deoxy-Delta12,14-prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: role of NF-kappaB and early growth response transcription factors. 51
HLA and Killer Cell Immunoglobulin-like Receptors Influence the Natural Course of CMV Infection. 50
Altered distribution of neutrophils and Nk cells in collagenase-induced osteoarthritis 49
Doxorubicin–Mediated miR–433 Expression on Exosomes Promotes Bystander Senescence in Multiple Myeloma Cells in a DDR–Independent Manner 48
Characterization of a Silencer Regulatory Element in the Interferon-gamma Promoter. 48
NKG2D down-modulation on human NK cells is followed by DNAM-1 hypo-responsivenss 47
Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. 46
Coupling of beta 1 integrin to Ras-MAP kinase pathways controls IFN gamma mRNA expression in human NK cells 45
NKG2D engagement on human NK cells leads to DNAM‐1 hypo‐responsiveness through different converging mechanisms 44
null 44
Hitting more birds with a stone: impact of TGF-β on ILC activity in cancer 43
Integrin-mediated ras-extracellular regulated kinase (ERK) signaling regulates interferon gamma production in human natural killer cells. 41
Gradual Loss of T-Helper-1 Population in Spleen of Mice During Progressive Tumor Growth. 41
When damage prevents cancer: the activation of the DNA damage response regulate the expression of DNAM-1 and NKG2D activating receptor ligands on human multiple myeloma cells 39
The senescence journey in cancer immunoediting 38
bc1-2 over-expression enhances NF-kappa B activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells 37
Differential shedding of the MICA and the MICB NKG2D ligands from multiple myeloma cells in response to genotoxic stress 37
NEGATIVE TRANSCRIPTIONAL REGULATION OF THE INTERFERON-GAMMA PROMOTER BY GLUCOCORTICOIDS AND DOMINANT-NEGATIVE MUTANTS OF C-JUN 36
Retinoic acid-induced transcriptional modulation of the human interferon-gamma promoter 35
Regulation of MICB shedding from multiple myeloma cells in response to genotoxic stress. 33
Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. 33
CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma 31
Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) in T lymphocytes 31
The cyclopentenone-type prostaglandin 15-deoxy-delta12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms 30
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells 25
Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing 25
Local immunotherapy of human bladder cancer with recombinant IL-2: activation of immune response and possible direct action of IL-2 on tumor cells. 22
Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells 22
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells 20
Local immunotherapy of superficial bladder cancer by intravesical instillation of recombinant interleukin-2. 20
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition 18
The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing. 11
Rescue SLAMF7 activity in exhausted natural killer cells: Novel challenges in the immunotherapy of multiple myeloma 9
SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses 9
Totale 5.325
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.049 0 0 0 82 115 232 170 128 146 91 46 39
2020/2021565 35 49 16 13 10 45 62 35 31 166 39 64
2021/2022758 3 45 92 34 93 18 25 78 47 55 147 121
2022/2023848 163 241 32 46 78 81 9 42 61 8 49 38
2023/2024698 24 79 38 57 87 129 33 27 16 108 50 50
2024/2025159 33 29 84 13 0 0 0 0 0 0 0 0
Totale 5.325